State Street
CAPR icon

State Street’s Capricor Therapeutics CAPR Stock Holding History

State Street’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$66.3M Buy
2,181,901
+1,352,380
+163% +$36M ﹤0.01% 1597
2025
Q4 		$23.9M Buy
829,521
+28,177
+4% +$368K ﹤0.01% 2155
2025
Q3 		$5.78M Sell
801,344
-665,341
-45% -$4.9M ﹤0.01% 2943
2025
Q2 		$14.6M Sell
1,466,685
-376,115
-20% -$3.97M ﹤0.01% 2360
2025
Q1 		$17.5M Sell
1,842,800
-365,568
-17% -$5.07M ﹤0.01% 2212
2024
Q4 		$30.5M Buy
2,208,368
+1,696,055
+331% +$29.7M ﹤0.01% 1977
2024
Q3 		$7.79M Buy
512,313
+111,291
+28% +$550K ﹤0.01% 2747
2024
Q2 		$1.91M Buy
401,022
+284,298
+244% +$1.59M ﹤0.01% 3331
2024
Q1 		$793K Buy
116,724
+31,500
+37% +$152K ﹤0.01% 3522
2023
Q4 		$417K Buy
85,224
+300
+0.4% +$976 ﹤0.01% 3687
2023
Q3 		$290K Hold
84,924
– – ﹤0.01% 3829
2023
Q2 		$406K Hold
84,924
– – ﹤0.01% 3748
2023
Q1 		$358K Hold
84,924
– – ﹤0.01% 3860
2022
Q4 		$328K Buy
84,924
+5,700
+7% +$27.2K ﹤0.01% 3916
2022
Q3 		$475K Hold
79,224
– – ﹤0.01% 3800
2022
Q2 		$276K Hold
79,224
– – ﹤0.01% 4068
2022
Q1 		$272K Buy
79,224
+7,476
+10% +$29.5K ﹤0.01% 4273
2021
Q4 		$210K Hold
71,748
– – ﹤0.01% 4328
2021
Q3 		$288K Hold
71,748
– – ﹤0.01% 4218
2021
Q2 		$368K Buy
+71,748
New +$304K ﹤0.01% 3973

Other funds holding CAPR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JHC
Jones Hill Capital New York $466M AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street's CAPR Position: Q1 2026 in Review

State Street increased its Capricor Therapeutics (CAPR) stake by 163% in Q1 2026, buying an estimated $36M and bringing the position to 2,181,901 shares worth $66.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1597.

State Street first reported a position in CAPR in Q2 2021 and has held it in 20 quarters since. 177 funds tracked by Wall St. Rank hold CAPR as of Q1 2026.

  • State Street held 2,181,901 shares of Capricor Therapeutics worth $66.3M as of Q1 2026.
  • State Street bought 1,352,380 Capricor Therapeutics shares in Q1 2026, an estimated $36M.
  • Capricor Therapeutics made up ﹤0.01% of State Street's portfolio in Q1 2026, its #1597 holding.
  • State Street first reported a position in Capricor Therapeutics in Q2 2021 and has held it in 20 quarters since.
  • 177 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.